Kim Norman is a U.S. board-certified toxicologist, European Registered Toxicologist and serves on the Board of Directors for the American Board of Toxicology. Kim joined the Personal Care Products Council (PCPC) as Senior Director, Safety and Regulatory Toxicology, in May 2022. In this role, she supports safety related issues for cosmetic ingredients and products, leading technical committees and engaging with domestic and international science and regulatory organizations. Kim previously served as an Associate Research Fellow in Global Stewardship at the Clorox Company, and as a Senior Toxicologist and Study Director at the Institute for In Vitro Sciences (IIVS). She has worked collaboratively on the development and regulatory acceptance of numerous assays replacing animal use in the personal care industry. Kim obtained her Ph.D. from Vanderbilt University in Cell and Developmental Biology studying the increased incidence of non-melanoma skin cancer in organ transplant recipients and DNA biomarkers in aging skin.

Download Presentation

Pablo Canamas is a doctor and engineer in the field of suncare products, and a great enthusiast of marine biology. After his graduation from ESPCI-PSL Paris, he acquired solid skills in physics, chemistry and biology, before leading a research project at the University of Hawaii on coral bleaching 5 years ago. After an applied PhD on the encapsulation of UV filters, Pablo now works at HELIOSCIENCE in Marseille as an R&D engineer. Since 2024, he has been setting up an ecotoxicity test on corals, with partners specializing in marine aquaculture. He is keen to propose appropriate solutions to cosmetics manufacturers and consumers and continues to raise awareness of marine biodiversity issues.

Pablo is happy to share his slides with 2025 Sunscreen Symposium™ attendees who email him directly at: p.canamas@helioscience.fr

Dr. David Demirjian is President at the Midwest Bioprocessing Center, a bioprocess company developing bio-based ingredients for human health and personal care. He also serves as CEO of zuChem, Inc which focuses on the biobased production of xylitol and mannitol. Dr. Demirjian was previously President and co-founder of ThermoGen, Inc. a bioprocessing company for pharmaceutical and food industry. He is a previous winner of the Research Director’s Association of Chicago “Entrepreneur of the Year Award” (1997) and recipient of the U.S. SBA “Tibbets Award” for successful commercialization of technology developed under the Federal SBIR grant program. Dr. Demirjian became VP of Technology Strategy for MediChem Life Sciences after their acquisition of ThermoGen (May 2000) and Demirjian helped lead their IPO (Oct. 2000) as VP of Technology Strategy. He holds a Ph.D. in Genetics from The University of Chicago and a B.S.A. from the University of Michigan.

Download Presentation